Six compounds identified from 70,000 to help eradicate malaria
Researchers from Imperial College London have identified 6 compounds from almost 70,000 that could help to eradicate malaria...
List view / Grid view
Researchers from Imperial College London have identified 6 compounds from almost 70,000 that could help to eradicate malaria...
A derivative of turmeric could be used in eye drops to treat the early stages of glaucoma...
Breath tests analysing organic compounds in exhaled breath could be used as a new diagnostic tool for pancreatic cancer...
The components of the immune system that trigger allergic reactions may also help protect the skin against cancer, suggest new findings...
Researchers have lab-tested a molecule that can combat the common cold virus by preventing it from hijacking human cells...
Researchers have discovered a new class of drug that has the potential to help cancer patients who no longer respond to existing therapies...
New imaging technology can be used to grade cancer tumours, eradicating human subjectivity and ensuring patients get the right treatment...
Scientists have become the first in the world to test how pathogens interact with artificial human organs...
Researchers have tested samples of N. gonorrhoeae from patients with infections in the throat, urethra, cervix and rectum, they found that at very low amounts closthioamide was effective...
Scientists have uncovered a way to ‘program’ immune cells to cause less damage to the body, by tapping into a ‘broken’ chemical pathway in inflammation.
Chemical signatures from gut bacteria which show up in urine can be used to predict how the body will respond to a 'junk' diet.
Dr Reda Lebcir from the University of Hertfordshire is part of an international team of researchers awarded a £2m grant from the ESRC (Economic and Social research Council).
A new study has found a link between certain brain receptors and obesity, giving a possible new drug target for appetite regulation.
The collaboration will provide MSc students with industry-relevant learning tools and pharma with a new pipeline of candidate compounds.
Investigators at Dartmouth's Geisel School of Medicine announced that two new studies of DAR-901, their investigational vaccine against tuberculosis (TB), have moved it to the forefront of new vaccines in development for global control of this deadly infectious disease.